TY  - GEN

T1  - <i>TP53</i>
                  abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia

T2  - openRxiv

UR  - https://doi.org/10.1101/2020.02.28.961391

PY  - 2020/02/28

AU  - Lai C

AU  - Vadakekolathu J

AU  - Reeder S

AU  - Church SE

AU  - Hood T

AU  - Aldoss I

AU  - Godwin J

AU  - Wieduwilt MJ

AU  - Arellano M

AU  - Muth J

AU  - Ravandi F et al

ED  - 

DO  - DOI: 10.1101/2020.02.28.961391

Y2  - 2026/02/25

ER  -